Oliver Wylie, BSc

Oliver trained as a Pharmacologist, but had an innate passion to follow his family heritage into the entrepreneurial world of business.

After working in commercial roles for GlaxoSmithKline, he was awarded a place of the fast track management programme for Smith Group, a FTSE 100. Projects included supply chain re-engineering for John Crane gas seals and the development of a new product for Smiths Medical with potential UK sales of £16million.

Other large corporate experience is with Stryker, where he helped develop a cloud based e-Healthcare tool to automate implant sizing and provide marketing tools for surgeons.

The ex-International President of J&J approached Oliver to help launch the first generic medical device manufacturer, aiming to disrupt this mature $450billion industry. He was integral in funding negotiations, leading lobby & policy strategy and global expansion. This was later named by a prominent UK Surgeon as "the biggest thing to happen to orthopaedics in 20 years".

Simultaneously, Oliver co-founded Amodisc with Ad Gandhe- engaging medical trainees & trainers through remote training tools.

Alongside being a panel member on groups such as the NHS Academic Health Sciences Networks, Oliver is a mentor on the NHS England Clinical Entrepreneur Programme and sits on the Board of companies ranging from AI, to operational workflow, diagnostics and mental health.

Cookies help us deliver our services. By using our services, you agree to our use of cookies.